Canopy Growth (WEED) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Jul, 2026Executive summary
The proxy statement outlines proposals for the 2026 Annual General and Special Meeting, including director elections, auditor re-appointment, share consolidation, by-law amendments, incentive plan renewal, and advisory votes on executive compensation and its frequency.
The meeting will be held virtually on September 25, 2026, with all shareholders encouraged to participate and vote electronically or by proxy.
The company emphasizes enhanced governance, risk oversight, and shareholder engagement, with updated policies and a focus on transparency.
Voting matters and shareholder proposals
Shareholders will vote on the election of five director nominees, re-appointment of PKF O'Connor Davies LLP as auditor, a share consolidation proposal, adoption of an advance notice by-law, renewal of the Omnibus Incentive Plan, a say-on-pay advisory vote, and a say-on-frequency advisory vote.
The board recommends voting FOR all proposals, including annual say-on-pay votes.
The share consolidation proposal allows the board to consolidate shares at a ratio of 1-for-5 to 1-for-15 within 12 months, primarily to maintain Nasdaq listing compliance.
The advance notice by-law formalizes the process for shareholder director nominations.
Board of directors and corporate governance
The board consists of five directors, four of whom are independent; the chair is independent.
Directors have diverse backgrounds in finance, consumer goods, cannabis, and governance.
The board and committees met frequently, with high attendance and regular in-camera sessions for independent directors.
Updated governance policies include an advance notice by-law and enhanced anti-bribery and anti-corruption measures.
Ongoing director education covers industry trends, regulatory changes, and strategic risks.
Latest events from Canopy Growth
- Shareholders will vote on board elections, share consolidation, and executive pay, with new ESG disclosures.WEED
Proxy filing7 Aug 2026 - Shareholders to vote on key governance, compensation, and capital structure proposals at the 2026 AGM.WEED
Proxy filing7 Aug 2026 - Net revenue rose 13% and adjusted EBITDA loss narrowed 59%, with improved margins and market share.WEED
Q1 20277 Aug 2026 - FY2026 net revenue rose 6% to $284.6M, driven by Canadian growth and MTL Cannabis acquisition.WEED
Investor presentation10 Jul 2026 - All proposals passed, with management highlighting U.S. regulatory opportunities and product innovation.WEED
AGM 20248 Jul 2026 - Revenue up 6%, margins improved, and cash position strengthened, with strong growth in Canada and Europe.WEED
Q4 202615 Jun 2026 - Acquisition creates Canada's top medical cannabis provider and accelerates profitability.WEED
M&A presentation16 Apr 2026 - Net loss narrowed 49% year-over-year as Canadian cannabis revenue grew and cost savings took hold.WEED
Q3 202613 Apr 2026 - Q3 FY2026 saw stable revenue, improved margins, and strategic moves to lead in cannabis markets.WEED
Investor presentation23 Mar 2026